All articles

Cell Therapy Market Map: 150+ Companies

150+ companies, 600+ programs, 7 approved products generating >$5B in sales. Cell therapy has hit a commercial inflection point.

Andrew Pannu
January 27, 2023

Download the Visual

Segmented by approach and highest development phase

  • 150+ companies with disclosed pipelines and 600+ programs in development
  • While the space is still early - only a few pivotal stage programs - with 7 approved products and >$5B in aggregate sales, cell therapy awareness has hit a commercial inflection point
  • Continued clinical proof-of-concept will drive further investment (i.e. J&J / LEGN's Carvykti announcement today)
Competitive Landscape

China Biopharma Landscape: 18,000+ Assets, 335 Deals, and the Gaps

Competitive Landscape

STAT6 Dermatology Landscape: 39 Programs, One Clinical Leader

Competitive Landscape

mTOR Non-Oncology Partnership Landscape: 144 Assets Mapped

Competitive Landscape

IL-6 Cardiovascular Landscape: 101 Programs, 3 Control the Window

Target Biology

AML Landscape: 957 Programs, 402 Targets, Opportunity Scored

Competitive Landscape

Cell Therapy Market Map: 150+ Companies

Competitive Landscape

Notable 2023 US Drug Approvals Ranked by Sales Estimates

Competitive Landscape

Gene Therapy Landscape (February 2023)

See what your team has been missing

Book a demoRead FAQ